Reports of increasing rates of cancer of the corpus uteri in several countries prompted this analysis of time trends. This study reports the trends in the incidence rate of cancer of the corpus uteri in Indian women. The data published in Cancer Incidence in Five Continents for various Indian registries for different periods and/or publication by the individual registries served as the source material. The mean annual percentage change in the incidence rates was computed using the relative difference between two time periods (latest and furthermost) and estimation of annual percentage change (EAPC) was also computed by the Poisson regression model. In 1998-2005, the incidence rate of cancer of the corpus uteri [age standardized rate (ASR)], was highest in Delhi and lowest in Pune and Imphal West (4.4 and 0.0 per 100,000 woman-years, respectively). The incidence rate in most of the registries between the two time periods showed an increase with few exceptions. Estimation of EAPC carried out in Mumbai, Chennai, and Bangalore PBCRs for the period 1983-2002 showed statistically significant increases in crude rate, ASR, and age-specific incidence rates (ASIR). The largest EAPC in ASR was in Bangalore (6.4%) and the smallest in Chennai (1.8%). Incidence trends for cancer of the corpus uteri appeared to result from an increase in the prevalence of risk factors and in improvement in diagnostic procedures. Most cancer of the corpus uteri is environmental in origin. Limiting fat consumption and avoiding excess energy intake may result in some reduction in the incidence of cancer of the corpus uteri.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/CEJ.0b013e3283410166 | DOI Listing |
J Transl Med
December 2024
Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Background: Mitochondrial transcription elongation factor (TEFM) is a recently discovered factor involved in mitochondrial DNA replication and transcription. Previous studies have reported that abnormal TEFM expression can disrupt the assembly of mitochondrial respiratory chain and thus mitochondrial function. However, the role of TEFM on Uterine corpus endometrial carcinoma (UCEC) progression remains unclear.
View Article and Find Full Text PDFJpn J Radiol
December 2024
Department of Radiology, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.
Objective: The purpose of this study was to evaluate MRI findings of ovarian endometrioid carcinoma (OEC) as a predictor of histological grade.
Materials And Methods: This study included 60 patients with histopathologically confirmed OEC (20, 30, and 10 with grades 1, 2, and 3, respectively). Clinical and MRI results were retrospectively reviewed.
Sci Rep
December 2024
IRCCS SYNLAB SDN, Via E. Gianturco 113, 80143, Naples, Italy.
Uterine corpus endometrial carcinoma (EC) is one of the most common malignancies in the female reproductive system, characterized by tumor heterogeneity at both radiological and pathological scales. Both radiomics and pathomics have the potential to assess this heterogeneity and support EC diagnosis. This study examines the correlation between radiomics features from Apparent Diffusion Coefficient (ADC) maps and post-contrast T1 (T1C) images with pathomic features from pathology images in 32 patients from the CPTAC-UCEC database.
View Article and Find Full Text PDFJ Gynecol Obstet Hum Reprod
December 2024
Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal; Portuguese Gynecologic Oncology Section of the Portuguese Society of Gynecology. Electronic address:
Background: The incidence of gynecological cancers in premenopausal women is increasing, highlighting issues related to Hormonal Contraception (HC) and Hormone Replacement Therapy (HRT). However, the presence of hormonal receptors in many gynecological cancers complicates HC and HRT prescriptions.
Objective: To identify barriers experienced by gynecologists in prescribing HC and HRT to gynecological cancer survivors, with a secondary objective of conducting a literature review on the safety of these prescriptions.
Int J Gynecol Pathol
December 2024
Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, P.R. China.
The incidence of neurotrophic tyrosine kinase receptor (NTRK) fusion uterine sarcoma is extremely low, and reports have been mostly focused on cases localized to the cervix. So far, only 4 cases have been reported of the uterine corpus. In this study, we reported a case of NTRK fusion corpus sarcoma.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!